Division of Rheumatology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.
Department of Medicine, University of Cambridge, Cambridge, UK.
Rheumatology (Oxford). 2021 Jun 18;60(6):2745-2754. doi: 10.1093/rheumatology/keaa699.
To determine the incidence rate, predictors and outcome of severe infections in a population-based cohort of ANCA-associated vasculitis (AAV).
The study included 325 cases of AAV (152 female) diagnosed from 1997 through 2016 from a defined geographic area in Sweden. All severe infection events (requiring hospitalization and treatment with intravenous antimicrobials) were identified. The Birmingham vasculitis activity score (BVAS) was used to evaluate disease activity, and organ damage was assessed using the vasculitis damage index (VDI). Patients were followed from time of AAV diagnosis to death or December 2017.
A total of 129 (40%) patients suffered at least one severe infection. In 2307 person-years (PY) of follow-up, 210 severe infections were diagnosed. The incidence rate of severe infections was 9.1/100 PY and was highest during the first year following AAV diagnosis at 22.1/100 PY (P < 0.001). Pneumonia, sepsis and urinary tract infection were the most common infections. Opportunistic infections constituted only 6% of all severe infections. In Cox regression analysis age and BVAS at diagnosis were the only factors independently predicting severe infection [hazard ratio: 1.54 (P < 0.001) and 1.27 (P = 0.001), respectively]. Severe infection was associated with poorer prognosis with respect to median VDI score 12 months post-AAV diagnosis, renal survival and mortality. Severe infections were the cause of death in 32 patients (22% of all deaths).
. Severe infection is a common problem in AAV, with the most important prognostic factors being older age and high disease activity at diagnosis. Severe infections are associated with permanent organ damage and high mortality.
在瑞典一个特定地理区域的基于人群的抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)队列中,确定严重感染的发生率、预测因素和结局。
该研究纳入了 1997 年至 2016 年期间确诊的 325 例 AAV 患者(152 例为女性)。所有严重感染事件(需要住院治疗并使用静脉用抗生素)均被确定。采用伯明翰血管炎活动评分(BVAS)评估疾病活动度,采用血管炎损伤指数(VDI)评估器官损伤。患者从 AAV 诊断开始随访至死亡或 2017 年 12 月。
共有 129 例(40%)患者发生至少一次严重感染。在 2307 人年的随访中,诊断出 210 例严重感染。严重感染的发生率为 9.1/100 人年,在 AAV 诊断后第一年最高,为 22.1/100 人年(P<0.001)。肺炎、脓毒症和尿路感染是最常见的感染。机会性感染仅占所有严重感染的 6%。在 Cox 回归分析中,年龄和诊断时的 BVAS 是唯一独立预测严重感染的因素[风险比:1.54(P<0.001)和 1.27(P=0.001)]。严重感染与 12 个月时的中位 VDI 评分、肾脏存活率和死亡率较差相关。严重感染是 32 例患者(所有死亡患者的 22%)死亡的原因。
严重感染是 AAV 的常见问题,最重要的预后因素是年龄较大和诊断时疾病活动度较高。严重感染与永久性器官损伤和高死亡率相关。